New filing

Lawsuit Alleges Dupixent Eczema Treatment Triggered Cutaneous T-Cell Lymphoma

New filing from the mass tort press

Headline as published by AboutLawsuits.com on Nov 17, 2026; collected by the wire Nov 17, 2026, 12:01 PM ET.

Read at AboutLawsuits.com

Coverage

  1. AboutLawsuits.com Mass tort press

    Lawsuit Alleges Dupixent Eczema Treatment Triggered Cutaneous T-Cell Lymphoma

Named in this story

Topics

Explore the named firms, organizations and MDL dockets above. Sources and method

MDL No. 3180

Dupixent

IN RE: Dupixent (Dupilumab) Products Liability Litigation

Transferee judge
Zahid N. Quraishi
Court
District of New Jersey
Actions pending
38

Per the JPML pending-dockets report of October 1, 2026.